Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Direct Oral Anticoagulant Versus Low Molecular Weight Heparin for the Treatment of Cancer-Associated Thromboembolism: 2021 Updated Meta-Analysis of Randomized Controlled Trials

Corinne Frere, Dominique Farge, Deborah Schrag, Pedro H. Prata, Jean M. Connors

Blood (2021) 138 (Supplement 1): 668.

https://doi.org/10.1182/blood-2021-150696

Published: 2021

Journal Articles

Improving Treatment Related Mortality over Time - Data from the Non-Observational Trial on Autologous Stem Cell Transplantation in Systemic Sclerosis By the EBMT Autoimmune Diseases Working Party (ADWP)

Dominique Farge, PhD MD, John A Snowden, MD PhD, Manuela Badoglio, Myriam Labopin, MD, Hans Ulrich Scherer, MD PhD, Nicoletta Del Papa, PhD MD, Lothar Kanz, Marc Schmalzing, MD, Thierry Martin, MD PhD, Montserrat Rovira, MD, Thomas Daikeler, MD PhD, Gregory Pugnet, MD PhD, Joerg Henes, MD PhD

Blood (2018) 132 (Supplement 1): 3431.

https://doi.org/10.1182/blood-2018-99-116602

Published: 2018

Journal Articles

Development and Validation of a 30-Day Mortality Prediction Model for Patients with Cancer-Associated Thrombosis (CAT) in the Riete Database

Harry E Fuentes, MD MS, Alfonso J Tafur, MD MS, RPVI, FSVM, Joseph A Caprini, MD MS, FACS, RVT, Adriano Alatri, MD, Javier Trujillo-Santos, MD, Dominique Farge-Bancel, MD PhD, Monreal Manuel, MD

Blood (2017) 130 (Supplement 1): 1094.

https://doi.org/10.1182/blood.V130.Suppl_1.1094.1094

Published: 2017

Journal Articles

Newly-Generated Regulatory B- and T-Cells Are Associated with Clinical Improvement and Reversal of Dermal Fibrosis in Systemic Sclerosis Patients after Autologous Hematopoietic Stem Cell Transplantation

Lucas C M Arruda, João R Lima-Júnior, Emmanuel Clave, Daniela A Moraes, Corinne Douay, Isabelle Fournier, Hélène Moins-Teisserenc, Dimas Tadeu Covas, MD, PhD, Kelen Malmegrim, Dominique Farge, Leandra Ramalho, Antoine Toubert, Maria Carolina Oliveira

Blood (2016) 128 (22): 4625.

https://doi.org/10.1182/blood.V128.22.4625.4625

Published: 2016

Journal Articles

Incidence and Risk Factors for Central Venous Catheter-Related Venous Thromboembolism in Breast Cancer Patients Under Neoadjuvant Chemotherapy: the Caveccas (Catheter Veineux Central et Cancer du Sein) Study

Philippe Debourdeau, MD, Marc Espié, MD, Sylvie Chevret, MD PhD, Joseph Gligorov, MD PhD, Antoine Elias, MD PhD, Pierre Francois Dupré, MD, Joel Le Long, MD, Sandrine Lavau-Denes, MD, Marie-Antoinette Sevestre, MD PhD, Laurent Bastit, MD, Issa Kalidi, MD, Corinne Frere, MD PhD, Dominique Farge, MD PhD

Blood (2016) 128 (22): 2607.

https://doi.org/10.1182/blood.V128.22.2607.2607

Published: 2016

Journal Articles

Quality of Life in Cancer Patients Undergoing Anticoagulant Treatment for Venous Thromboembolism: The Quavitec Study

Dominique Farge, MD PhD, Nicolas Falvo, MD, Matthieu Resche-Rigon, MD PhD, Toufek Berremili, MD, Francis Couturaud, MD PhD, Okba Bensaoula, MD, Lionel Védrine, MD, Isabelle Bonnet, MD, Denis Péré-Vergé, MD, Marie Coudurier, MD, Veronique Li, MD, Francis Cajfinger, MD

Blood (2016) 128 (22): 880.

https://doi.org/10.1182/blood.V128.22.880.880

Published: 2016

Journal Articles

Accredited Interactive Web-Based Application for the 2016 International Clinical Practice Guidelines on Thrombosis in Cancer: Improving Knowledge Transfer in Daily Clinical Practice

Dominique Farge, MD PhD

Blood (2016) 128 (22): 5954.

https://doi.org/10.1182/blood.V128.22.5954.5954

Published: 2016

Journal Articles

Autologous Hematopoietic Stem Cell Transplantation (AHSCT) in Severe Auto-Immune Disease Adult Patients: Analysis of Outcomes from the French Society for Bone Marrow Transplantation and Cellular Therapy (SFGMT-TC) in Light of the European Society for Blood and Marrow Transplantation (EBMT) Activity

Perrine Guillaume-Jugnot, MD, Zora Marjanovic, Myriam Labopin, MD, Louis Terriou, MD, Christophe Deligny, Bruno Lioure, MD, Thierry Martin, Veronique Leblond, MD PhD, Gregory Pugnet, Didier Blaise, Régis Peffault de Latour, MD, Ibrahim Yakoub-Agha, MD PhD, John A Snowden, MD FRCP, FRCPath, Dominique Farge, PhD MD

Blood (2015) 126 (23): 1985.

https://doi.org/10.1182/blood.V126.23.1985.1985

Published: 2015

Journal Articles

Long-Term Use of Low-Molecular-Weight Heparin (LMWH) for Cancer-Associated Venous Thromboembolism (VTE): Adherence to Recommendations in Clinical Practice Based on Tropique, a Prospective Non-Interventional Observational Study

Dominique Farge, PhD MD, Norbert Claude Gorin, MD PhD, Philippe Debourdeau, MD, Anne Lamblin, Francis Cajfinger, MD

Blood (2014) 124 (21): 1545.

https://doi.org/10.1182/blood.V124.21.1545.1545

Published: 2014

Journal Articles

Long-Term Use of Low-Molecular-Weight Heparins (LMWH) for Cancer-Associated Venous Thromboembolism (VTE): Patients’ Perception in Tropique, a Prospective, Multicenter, Observational Study

Dominique Farge, PhD MD, Philippe Debourdeau, MD, Norbert Claude Gorin, MD PhD, Anne Lamblin, Francis Cajfinger, MD

Blood (2014) 124 (21): 4272.

https://doi.org/10.1182/blood.V124.21.4272.4272

Published: 2014

Journal Articles

Long-Term Efficacy and Safety of Low-Molecular-Weight Heparins (LMWH) for Cancer-Associated Venous Thromboembolism (VTE) in Tropique, a Prospective Non-Interventional Observational Study

Dominique Farge, PhD MD, Philippe Debourdeau, MD, Norbert Claude Gorin, MD PhD, Anne Lamblin, Francis Cajfinger, MD

Blood (2014) 124 (21): 4273.

https://doi.org/10.1182/blood.V124.21.4273.4273

Published: 2014

Journal Articles

Does Ex Vivo CD34+ Cell Selection Change the Outcome of Systemic Sclerosis Patients Treated with Autologous Hematopoietic Stem Cell Transplantation (AHSCT), an Adwp EBMT Study?

Maria Carolina Oliveira, MD PhD, Myriam Labopin, MD, Jörg Henes, MD PhD, John Moore, MD, Nicoletta Del Papa, MD PhD, Ricca Stanciu, Ioanna Sakellari, MD PhD, Roland Schroers, MD, Hans Ulrich Scherer, MD, Slawomira Kyrcz-Krzemien, MD PhD Prof., Thomas Daikeler, MD, Tobias Alexander, Jürgen Finke, MD, Manuela Badoglio, John A Snowden, MD FRCP, FRCPath, Dominique Farge, MD PhD

Blood (2014) 124 (21): 2517.

https://doi.org/10.1182/blood.V124.21.2517.2517

Published: 2014

Journal Articles

Outcome Of Pregnancy After Autologous Hematopoietic Stem Cell Transplantation (AHSCT) For Autoimmune Diseases (AD): A Retrospective Study Of The EBMT Autoimmune Diseases Working Party (ADWP)

Emilian Snarski, John A Snowden, MD, FRCP, FRCPath, Manuela Badoglio, Kristina Carlson, Joachim Burman, MD, Maria Carolina Oliveira, John Moore, Jeffrey Tan, Montserrat Rovira, MD, Richard E Clark, MD, Albert Saiz, Sondess Hadj Khelifa, Alessandra Crescimanno, Lynne Laing, Maurizio Musso, Thierry Martin, Dominique Farge, MD

Blood (2013) 122 (21): 4640.

https://doi.org/10.1182/blood.V122.21.4640.4640

Published: 2013

Journal Articles

Autologous Hematopoietic Stem Cell Transplantation In Neuromyelitis Optica: A Retrospective Study Of The EBMT Autoimmune Diseases Working Party In Collaboration With The University Of Sao Paulo, Ribeirao Preto, Brazil

Raffaella Greco, MD, Attilio Bondanza, MD, PhD, Manuela Badoglio, Myriam Labopin, MD, Maria Carolina Oliveira, MD, Gian Luigi Mancardi, MD, Simona Minguzzi, RN, Joachim Burman, MD, Fredrik Piehl, MD, PhD, Hans Hagglund, MD, PhD, Eva Krasulova, PhD, Giancarlo Comi, MD, Fabio Ciceri, MD, Dominique Farge, MD

Blood (2013) 122 (21): 2125.

https://doi.org/10.1182/blood.V122.21.2125.2125

Published: 2013

Journal Articles

New autoimmune diseases after cord blood transplantation: a retrospective study of EUROCORD and the Autoimmune Disease Working Party of the European Group for Blood and Marrow Transplantation

Blood (2013) 121 (6): 1059–1064.

https://doi.org/10.1182/blood-2012-07-445965

Published: 2013

Includes: Supplemental data

Journal Articles

Secondary autoimmune diseases occurring after HSCT for an autoimmune disease: a retrospective study of the EBMT Autoimmune Disease Working Party

Blood (2011) 118 (6): 1693–1698.

https://doi.org/10.1182/blood-2011-02-336156

Published: 2011

Journal Articles

Incidence and Risk Factors for Secondary Autoimmune Diseases (AD) After Cord Blood Transplantation (CBT). Retrospective Analysis on Behalf of Eurocord and the EBMT Autoimmune Diseases Working Party.

Blood (2010) 116 (21): 3460.

https://doi.org/10.1182/blood.V116.21.3460.3460

Published: 2010

Journal Articles

Incidence and Risk Factors for Secondary Autoimmune Diseases (AD) After Hematopoietic Stem Cell Transplantation (HSCT) for a Severe Autoimmune Disease-A Retrospective EBMT WP AD Study

Blood (2010) 116 (21): 2322.

https://doi.org/10.1182/blood.V116.21.2322.2322

Published: 2010

Journal Articles

2008 Guidelines for the Treatment of Venous Thromboembolism in Cancer Patients: Report from the French Working Group.

Blood (2008) 112 (11): 1284.

https://doi.org/10.1182/blood.V112.11.1284.1284

Published: 2008

Journal Articles

Autologous Hematopoietic Stem Cell Transplantation (HSCT) for Autoimmune Diseases: 10 Years Experience from the European Group for Blood and Marrow Transplantation (EBMT) Working Party on Autoimmune Diseases

Dominique Farge, Myriam Labopin, Alan Tyndall, Athanasios Fassas, Gian Luigi Mancardi, Jaap Van Laar, Jian Ouyang, Tomas Kozak, John Moore, Ina Kötter, Virginie Chesnel, Alberto Marmont, Alois Gratwohl, MD, Riccardo Saccardi

Blood (2008) 112 (11): 164.

https://doi.org/10.1182/blood.V112.11.164.164

Published: 2008

NARROW

Direct Oral Anticoagulant Versus Low Molecular Weight Heparin for the Treatment of Cancer-Associated Thromboembolism: 2021 Updated Meta-Analysis of Randomized Controlled Trials

Improving Treatment Related Mortality over Time - Data from the Non-Observational Trial on Autologous Stem Cell Transplantation in Systemic Sclerosis By the EBMT Autoimmune Diseases Working Party (ADWP)

Development and Validation of a 30-Day Mortality Prediction Model for Patients with Cancer-Associated Thrombosis (CAT) in the Riete Database

Newly-Generated Regulatory B- and T-Cells Are Associated with Clinical Improvement and Reversal of Dermal Fibrosis in Systemic Sclerosis Patients after Autologous Hematopoietic Stem Cell Transplantation

Incidence and Risk Factors for Central Venous Catheter-Related Venous Thromboembolism in Breast Cancer Patients Under Neoadjuvant Chemotherapy: the Caveccas (Catheter Veineux Central et Cancer du Sein) Study

Quality of Life in Cancer Patients Undergoing Anticoagulant Treatment for Venous Thromboembolism: The Quavitec Study

Accredited Interactive Web-Based Application for the 2016 International Clinical Practice Guidelines on Thrombosis in Cancer: Improving Knowledge Transfer in Daily Clinical Practice

Autologous Hematopoietic Stem Cell Transplantation (AHSCT) in Severe Auto-Immune Disease Adult Patients: Analysis of Outcomes from the French Society for Bone Marrow Transplantation and Cellular Therapy (SFGMT-TC) in Light of the European Society for Blood and Marrow Transplantation (EBMT) Activity

Long-Term Use of Low-Molecular-Weight Heparin (LMWH) for Cancer-Associated Venous Thromboembolism (VTE): Adherence to Recommendations in Clinical Practice Based on Tropique, a Prospective Non-Interventional Observational Study

Long-Term Use of Low-Molecular-Weight Heparins (LMWH) for Cancer-Associated Venous Thromboembolism (VTE): Patients’ Perception in Tropique, a Prospective, Multicenter, Observational Study

Long-Term Efficacy and Safety of Low-Molecular-Weight Heparins (LMWH) for Cancer-Associated Venous Thromboembolism (VTE) in Tropique, a Prospective Non-Interventional Observational Study

Does Ex Vivo CD34+ Cell Selection Change the Outcome of Systemic Sclerosis Patients Treated with Autologous Hematopoietic Stem Cell Transplantation (AHSCT), an Adwp EBMT Study?

Outcome Of Pregnancy After Autologous Hematopoietic Stem Cell Transplantation (AHSCT) For Autoimmune Diseases (AD): A Retrospective Study Of The EBMT Autoimmune Diseases Working Party (ADWP)

Autologous Hematopoietic Stem Cell Transplantation In Neuromyelitis Optica: A Retrospective Study Of The EBMT Autoimmune Diseases Working Party In Collaboration With The University Of Sao Paulo, Ribeirao Preto, Brazil

New autoimmune diseases after cord blood transplantation: a retrospective study of EUROCORD and the Autoimmune Disease Working Party of the European Group for Blood and Marrow Transplantation

Secondary autoimmune diseases occurring after HSCT for an autoimmune disease: a retrospective study of the EBMT Autoimmune Disease Working Party

Incidence and Risk Factors for Secondary Autoimmune Diseases (AD) After Cord Blood Transplantation (CBT). Retrospective Analysis on Behalf of Eurocord and the EBMT Autoimmune Diseases Working Party.

Incidence and Risk Factors for Secondary Autoimmune Diseases (AD) After Hematopoietic Stem Cell Transplantation (HSCT) for a Severe Autoimmune Disease-A Retrospective EBMT WP AD Study

2008 Guidelines for the Treatment of Venous Thromboembolism in Cancer Patients: Report from the French Working Group.

Autologous Hematopoietic Stem Cell Transplantation (HSCT) for Autoimmune Diseases: 10 Years Experience from the European Group for Blood and Marrow Transplantation (EBMT) Working Party on Autoimmune Diseases

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only